Finance

Lists
1801:HKG
Innovent Biologics Inc
HK$ ८९.०५
+१.४८%
(+१.३०) 1D
अक्टोबर १६, १६:०८:१४ GMT+८  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1801...
Open
HK$ ९१.२५
High
HK$ ९२.४५
Low
HK$ ८८.००
Mkt. cap
१.५६ खरब
Avg. vol.
९९.०९ लाख
Volume
९६.९४ लाख
P/E ratio
१११.०८
52-wk high
HK$ ११२.७०
52-wk low
HK$ ६९.५५
EPS
HK$ ०.८०
No. of employees
९ हजार
Open
HK$ ९१.२५
High
HK$ ९२.४५
Low
HK$ ८८.००
Mkt. cap
१.५६ खरब
Avg. vol.
९९.०९ लाख
Volume
९६.९४ लाख
P/E ratio
१११.०८
52-wk high
HK$ ११२.७०
52-wk low
HK$ ६९.५५
EPS
HK$ ०.८०
No. of employees
९ हजार
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
१ दिन पहिले
Juyuan Research raises target for Innovent stock to HKD 138.63
Profile
Innovent Biologics, Inc. is a publicly listed Chinese biopharmaceutical company that is headquartered in Suzhou, Jiangsu. Wikipedia
About Innovent Biologics Inc
CEOMichael Yu
Employees८.७५ हजार
Founded२०११ नोभेम्बर २८
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
३.५४ अरब
३.५४ अरब
४.३१ अरब
४.३१ अरब
Cost of goods sold
८४.५१ करोड
८४.५१ करोड
९९.९३ करोड
९९.९३ करोड
Cost of revenue
८४.५१ करोड
८४.५१ करोड
९९.९३ करोड
९९.९३ करोड
Research and development expenses
८०.७७ करोड
८०.७७ करोड
८४.१९ करोड
८४.१९ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.९१ अरब
१.९१ अरब
१.८६ अरब
१.८६ अरब
Operating expense
२.७२ अरब
२.७२ अरब
२.७१ अरब
२.७१ अरब
Total operating expenses
३.५६ अरब
३.५६ अरब
३.७१ अरब
३.७१ अरब
Operating income
-२.०० करोड
-२.०० करोड
६०.२८ करोड
६०.२८ करोड
Other non operating income
४.५२ करोड
४.५२ करोड
३.१६ करोड
३.१६ करोड
EBT including unusual items
-२.९१ करोड
-२.९१ करोड
८०.५८ करोड
८०.५८ करोड
EBT excluding unusual items
-१५.९० लाख
-१५.९० लाख
७३.८१ करोड
७३.८१ करोड
Income tax expense
-१.८७ करोड
-१.८७ करोड
१७.९३ करोड
१७.९३ करोड
Effective tax rate
६४.३३%
६४.३३%
२२.२५%
२२.२५%
Other operating expenses
-
-
-
-
Net income
-१.०४ करोड
-१.०४ करोड
६२.६६ करोड
६२.६६ करोड
Net profit margin
-०.२९%
-०.२९%
१४.५४%
१४.५४%
Earnings per share
-
-
-
-
Interest and investment income
१२.४२ करोड
१२.४२ करोड
१७.८१ करोड
१७.८१ करोड
Interest expense
-९१.६७ लाख
-९१.६७ लाख
-२.०५ करोड
-२.०५ करोड
Net interest expenses
११.५० करोड
११.५० करोड
१५.७७ करोड
१५.७७ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१४.०३ करोड
१४.०३ करोड
७६.१४ करोड
७६.१४ करोड
Gain or loss from assets sale
-७१.०० हजार
-७१.०० हजार
१३.६२ लाख
१३.६२ लाख
AI content may include mistakes. Learn more
Google एपहरू